Bharat Biotech reduces Covaxin's price from ₹600 to ₹400 per dose for states

Bharat Biotech on Thursday announced it will charge state governments ₹400 for a dose of Covaxin, instead of ₹600, as earlier announced. The move comes a day after Pune's Serum Institute of India brought down the price from ₹400 to ₹300 for state governments.

Bharat Biotech

Expressing deep concerns over the present pandemic situation of the country, Bharat Biotech said, "We wish to be transparent in our approach to pricing which was determined by internally funded product development, several operationally intensive BSL-3 manufacturing facilities (the first of its kind on our country) and clinical trials."

"Recognising the enormous challenges to the public health care system, we have made Covaxin available to state governments at a price of ₹400 per dose," the Hyderabad-based company said.

The third phase of vaccination

The third phase of vaccination against Covid-19 will begin from May 1 in which people between the age group of 18 and 44 years will be considered eligible to get vaccine doses. As this is an extension of the ongoing vaccination drive of the country, the Centre has allowed state governments and private hospitals to procure vaccines separately from the makers.

Following the Centre's order on liberalising the vaccine drive, both Serum Insitute and Bharat Biotech announced the market price of their vaccines Covishield and Covaxin, respectively. While one dose of Covishield was initially priced at ₹400 for states and ₹600 for private hospitals, one dose of Covaxin was initially priced at ₹600 for states and ₹1,200 for private hospitals. The Centre, meanwhile, claimed that it will continue procure both the vaccines at ₹150 per dose and will dispatch to states as it has been doing so far.

Stay tuned with the newstrack to get fastest updates. Click @englishnewstrack to follow us on Facebook and @newstrackmedia to follow on Twitter.